Ranbaxy’s chronic maladies. An Indian firm at the forefront of the revolution in cheap generic medicines hits fresh troubles

The Economist [2013], “Ranbaxy’s chronic maladies. An Indian firm at the forefront of the revolution in cheap generic medicines hits fresh troubles", The Economist, London, 19 de septiembre, http://www.economist.com/news/business/21586537-indian-firm-forefront-re...